209 related articles for article (PubMed ID: 18588983)
1. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
Nisius L; Rogowski M; Vangelista L; Grzesiek S
Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
[TBL] [Abstract][Full Text] [Related]
2. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
3. Recognition of RANTES by extracellular parts of the CCR5 receptor.
Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
[TBL] [Abstract][Full Text] [Related]
4. Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.
Owais M; Arya SK
J Hum Virol; 1999; 2(5):270-82. PubMed ID: 10551733
[TBL] [Abstract][Full Text] [Related]
5. Study on CCR5 analogs and affinity peptides.
Wu Y; Deng R; Wu W
Protein Eng Des Sel; 2012 Mar; 25(3):97-105. PubMed ID: 22238429
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES.
Nardese V; Longhi R; Polo S; Sironi F; Arcelloni C; Paroni R; DeSantis C; Sarmientos P; Rizzi M; Bolognesi M; Pavone V; Lusso P
Nat Struct Biol; 2001 Jul; 8(7):611-5. PubMed ID: 11427892
[TBL] [Abstract][Full Text] [Related]
7. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
[TBL] [Abstract][Full Text] [Related]
8. The molecular cloning and functional expression of the dog CCR5.
Mosley M; Pullen S; Botham A; Gray A; Napier C; Mansfield R; Holbrook M
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):415-20. PubMed ID: 16806494
[TBL] [Abstract][Full Text] [Related]
9. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
Zheng Y; Han GW; Abagyan R; Wu B; Stevens RC; Cherezov V; Kufareva I; Handel TM
Immunity; 2017 Jun; 46(6):1005-1017.e5. PubMed ID: 28636951
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction.
Zhou N; Luo Z; Hall JW; Luo J; Han X; Huang Z
Eur J Immunol; 2000 Jan; 30(1):164-73. PubMed ID: 10602038
[TBL] [Abstract][Full Text] [Related]
11. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.
Blanpain C; Vanderwinden JM; Cihak J; Wittamer V; Le Poul E; Issafras H; Stangassinger M; Vassart G; Marullo S; Schlndorff D; Parmentier M; Mack M
Mol Biol Cell; 2002 Feb; 13(2):723-37. PubMed ID: 11854425
[TBL] [Abstract][Full Text] [Related]
12. Construction, purification, and immunogenicity of recombinant cystein-cystein type chemokine receptor 5 vaccine.
Wu K; Xue X; Wang Z; Yan Z; Shi J; Han W; Zhang Y
Protein Expr Purif; 2006 Sep; 49(1):108-13. PubMed ID: 16600624
[TBL] [Abstract][Full Text] [Related]
13. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.
Mirzabekov T; Kontos H; Farzan M; Marasco W; Sodroski J
Nat Biotechnol; 2000 Jun; 18(6):649-54. PubMed ID: 10835604
[TBL] [Abstract][Full Text] [Related]
14. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
15. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.
Desmetz C; Lin YL; Mettling C; Portalès P; Rabesandratana H; Clot J; Corbeau P
Immunology; 2006 Dec; 119(4):551-61. PubMed ID: 17177831
[TBL] [Abstract][Full Text] [Related]
16. Purification and partial characterization of R5, R5X4, and X4 HIV-1 subtype C envelope glycoproteins expressed in insect cells.
Nkosi SP; Huismans H; Papathanasopoulos MA
J Med Virol; 2005 Aug; 76(4):459-63. PubMed ID: 15977243
[TBL] [Abstract][Full Text] [Related]
17. Identification of amino acid residues crucial for chemokine receptor dimerization.
Hernanz-Falcón P; Rodríguez-Frade JM; Serrano A; Juan D; del Sol A; Soriano SF; Roncal F; Gómez L; Valencia A; Martínez-A C; Mellado M
Nat Immunol; 2004 Feb; 5(2):216-23. PubMed ID: 14716309
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
Morikis D; Rizos AK; Spandidos DA; Krambovitis E
Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
[TBL] [Abstract][Full Text] [Related]
19. GPCR expression using baculovirus-infected Sf9 cells.
Aloia AL; Glatz RV; McMurchie EJ; Leifert WR
Methods Mol Biol; 2009; 552():115-29. PubMed ID: 19513645
[TBL] [Abstract][Full Text] [Related]
20. Relative concordance of human immunodeficiency virus oligomeric and monomeric envelope in CCR5 coreceptor usage.
Teeravechyan S; Suphaphiphat P; Essex M; Lee TH
Virology; 2008 Jan; 370(2):443-50. PubMed ID: 17936869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
